Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology

Overview Zen Score Price Valuation Financials

Forecast Earnings & Revenue Dividends Ownership Technicals

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
ADIL	ADIAL PHARMACEUTICALS INC	$6.85M	-183.30%	-134.10%	-125.46%	-402.00%	0.16	4.90	N/A	N/A	N/A
ACLX	ARCELLX INC	$2.70B	-21.00%	-10.50%	-9.36%	-19.60%	0.70	6.06	100.00%	-64.10%	-59.99%
ACRV	ACRIVON THERAPEUTICS INC	$226.37M	-42.50%	-39.00%	-48.33%	-51.40%	0.14	9.75	N/A	N/A	N/A
AEZS	AETERNA ZENTARIS INC	$9.48M	-63.20%	-37.30%	-50.97%	2,552.40%	1.03	8.01	95.10%	-368.00%	-367.99%
ANTX	AN2 THERAPEUTICS INC	$70.56M	-59.70%	-53.70%	-51.91%	-81.40%	0.11	7.87	N/A	N/A	N/A
CTXR	CITIUS PHARMACEUTICALS INC	$110.09M	-43.20%	-37.90%	-40.95%	-60.70%	0.14	5.06	N/A	N/A	N/A
DAWN	DAY ONE BIOPHARMACEUTICALS INC	$1.44B	-51.70%	-48.30%	-54.52%	-100.10%	0.09	12.72	N/A	N/A	N/A
CYTO	ALTAMIRA THERAPEUTICS LTD	$2.32M	N/A	-55.30%	-32.34%	250.00%	0.19	1.38	N/A	N/A	N/A
NUVL	NUVALENT INC	$4.35B	-25.70%	-24.50%	-18.02%	-36.70%	0.05	22.83	N/A	N/A	N/A
GRTS	GRITSTONE BIO INC	$79.04M	-147.20%	-69.50%	-89.38%	-62.90%	2.43	3.20	100.00%	-847.30%	-822.65%
PYXS	PYXIS ONCOLOGY INC	$258.11M	-52.60%	-41.10%	-49.87%	-51.60%	0.38	4.84	N/A	N/A	N/A
IGC	IGC PHARMA INC	$29.51M	-110.40%	-93.30%	-151.72%	-146.30%	0.24	1.85	51.40%	-1,163.20%	-1,163.24%
IONS	IONIS PHARMACEUTICALS INC	$6.12B	-90.60%	-12.40%	-9.93%	-6.90%	6.73	5.90	98.80%	-46.50%	-32.06%
NKTR	NEKTAR THERAPEUTICS	$268.08M	-151.60%	-58.20%	-72.36%	-51.60%	2.04	6.45	62.50%	-306.30%	-278.42%
VBIV	VBI VACCINES INC	$16.04M	-462.40%	-92.80%	-770.71%	-325.70%	10.55	0.48	-44.10%	-1,080.90%	-995.57%
JSPR	JASPER THERAPEUTICS INC	$330.20M	-63.20%	-55.10%	-78.12%	-13,395.30%	0.21	7.19	N/A	N/A	N/A
LIPO	LIPELLA PHARMACEUTICALS INC	$4.53M	-150.10%	-127.20%	-144.37%	-3,314.50%	0.14	8.90	100.00%	-1,027.30%	-1,024.90%
TENX	TENAX THERAPEUTICS INC	$7.19M	-65.80%	-58.30%	-94.92%	9,839.40%	0.44	3.26	N/A	N/A	N/A
TCON	TRACON PHARMACEUTICALS INC	$4.27M	N/A	-35.90%	-4,825.97%	-43.70%	-13.49	0.89	100.00%	-29.80%	30.85%
SONN	SONNET BIOTHERAPEUTICS HOLDINGS INC	$5.46M	-519.50%	-169.50%	-538.83%	518.10%	1.08	1.74	100.00%	-11,193.30%	-11,193.30%
UBX	UNITY BIOTECHNOLOGY INC	$25.35M	-92.40%	-45.50%	-64.66%	-41.80%	1.31	5.95	N/A	N/A	N/A
OBIO	ORCHESTRA BIOMED HOLDINGS INC	$157.06M	-58.30%	-41.50%	-58.47%	-53.30%	0.40	7.95	93.30%	-1,779.70%	-1,779.71%
VALN	VALNEVA SE	$534.12M	-59.60%	-19.20%	-25.00%	-28.00%	2.59	1.65	34.40%	-66.00%	-48.99%
VKTX	VIKING THERAPEUTICS INC	$8.32B	-18.40%	-17.70%	-10.03%	-22.20%	0.04	29.49	N/A	N/A	N/A
TRDA	ENTRADA THERAPEUTICS INC	$414.64M	-2.90%	-1.40%	3.88%	4.30%	0.94	2.33	100.00%	-5.20%	9.34%
TCBP	TC BIOPHARM (HOLDINGS) PLC	$4.76M	-444.20%	-59.40%	-165.33%	-650.10%	2.33	1.20	N/A	N/A	N/A
ABUS	ARBUTUS BIOPHARMA CORP	$498.99M	-57.80%	-43.40%	-59.38%	-61.20%	0.36	5.87	100.00%	-401.60%	-399.04%
AVTE	AEROVATE THERAPEUTICS INC	$572.58M	-61.60%	-55.10%	-68.74%	-85.70%	0.16	7.04	N/A	N/A	N/A
ENTA	ENANTA PHARMACEUTICALS INC	$280.32M	-60.40%	-32.30%	-34.80%	-39.70%	1.23	6.25	100.00%	-187.80%	-173.07%
GLUE	MONTE ROSA THERAPEUTICS INC	$281.36M	-65.90%	-47.30%	-52.50%	-57.90%	0.70	5.07	N/A	N/A	N/A
IKT	INHIBIKASE THERAPEUTICS INC	$10.30M	-107.50%	-91.80%	-171.93%	-177.60%	0.32	4.13	100.00%	-7,304.70%	-7,304.73%
MOR	MORPHOSYS AG	$2.61B	-183.80%	-8.60%	-2.78%	-2.10%	40.31	3.08	75.50%	-79.60%	-20.54%
ASND	ASCENDIS PHARMA A	$8.09B	-14,914.70%	-55.20%	-68.46%	-52.70%	-6.67	3.56	83.40%	-180.50%	-161.25%
GERN	GERON CORP	$2.26B	-63.30%	-44.70%	-61.47%	-53.50%	0.59	3.16	100.00%	-77,690.70%	-74,183.54%
SEEL	SEELOS THERAPEUTICS INC	$3.83M	N/A	-321.30%	112.82%	178.70%	-1.16	0.14	100.00%	-1,719.60%	-1,716.16%
GANX	GAIN THERAPEUTICS INC	$48.66M	-193.00%	-123.20%	-162.44%	-340.30%	0.48	3.59	100.00%	-40,354.30%	-40,210.67%
BTAI	BIOXCEL THERAPEUTICS INC	$78.89M	N/A	-144.90%	-356.93%	-214.00%	-2.30	2.65	8.70%	-12,974.90%	-12,010.07%
LGVN	LONGEVERON INC	$4.25M	-216.90%	-141.90%	-261.48%	-265.30%	0.79	1.50	31.20%	-3,132.70%	-3,020.17%
TNXP	TONIX PHARMACEUTICALS HOLDING CORP	$15.12M	-87.70%	-73.80%	-86.05%	-112.30%	0.46	2.53	39.00%	-1,501.80%	-1,501.78%
PYPD	POLYPID LTD	$7.89M	-1,267.70%	-115.40%	-282.80%	-126.20%	-8.33	0.83	N/A	N/A	N/A
MRSN	MERSANA THERAPEUTICS INC	$383.32M	-282.40%	-62.60%	-103.19%	-201.60%	5.13	3.36	100.00%	-465.80%	-454.75%
SGMO	SANGAMO THERAPEUTICS INC	$93.39M	-131.00%	-89.60%	-223.58%	-134.60%	1.00	1.98	100.00%	-146.30%	-149.18%
FNCH	FINCH THERAPEUTICS GROUP INC	$3.69M	-273.00%	-114.70%	-155.56%	-140.30%	1.42	6.33	100.00%	-69,863.60%	-74,565.42%
EYEN	EYENOVIA INC	$33.74M	-213.30%	-89.20%	-129.30%	-123.30%	2.20	2.17	200.00%	-719,859.90%	-657,228.55%
XNCR	XENCOR INC	$1.29B	-18.70%	-15.20%	-13.86%	-15.80%	0.42	7.36	100.00%	-74.90%	-71.45%
FENC	FENNEC PHARMACEUTICALS INC	$247.69M	N/A	-73.60%	-65.51%	-44.90%	-3.31	3.56	94.10%	-75.50%	-59.53%
BLTE	BELITE BIO INC	$1.19B	-48.00%	-45.50%	-34.72%	-1,349.20%	0.05	24.76	N/A	N/A	N/A
SLN	SILENCE THERAPEUTICS PLC	$865.92M	-262.60%	-47.00%	-63.32%	-257.50%	4.50	4.56	59.30%	-170.50%	-189.79%
PEPG	PEPGEN INC	$377.90M	-57.60%	-45.60%	-62.58%	-176.50%	0.32	6.43	N/A	N/A	N/A
SLDB	SOLID BIOSCIENCES INC	$331.88M	-62.10%	-49.00%	-63.83%	-87.50%	0.30	8.94	N/A	N/A	N/A
APGE	APOGEE THERAPEUTICS INC	$2.48B	-49.50%	-30.50%	-22.05%	-72.60%	0.06	19.38	N/A	N/A	N/A
SLRX	SALARIUS PHARMACEUTICALS INC	$2.09M	-198.00%	-135.20%	-237.22%	611.60%	0.25	5.02	N/A	N/A	N/A
NERV	MINERVA NEUROSCIENCES INC	$16.85M	N/A	-50.30%	-56.02%	1,517.00%	-3.00	12.57	N/A	N/A	N/A
RLYB	RALLYBIO CORP	$69.95M	-56.90%	-53.40%	-70.11%	-72.50%	0.09	12.39	N/A	N/A	N/A
TNYA	TENAYA THERAPEUTICS INC	$356.46M	-69.90%	-59.80%	-83.96%	-94.80%	0.22	4.91	N/A	N/A	N/A
MLYS	MINERALYS THERAPEUTICS INC	$613.94M	-26.50%	-25.50%	-29.81%	-40.40%	0.04	23.77	N/A	N/A	N/A
RPHM	RENEO PHARMACEUTICALS INC	$55.81M	-73.20%	-63.90%	-86.70%	-87.30%	0.21	5.87	N/A	N/A	N/A
VIRX	VIRACTA THERAPEUTICS INC	$32.24M	-145.60%	-71.50%	-258.50%	-82.80%	2.10	1.43	N/A	N/A	N/A
KPTI	KARYOPHARM THERAPEUTICS INC	$126.57M	N/A	-50.50%	-69.58%	-35.80%	-2.77	3.37	96.60%	-98.00%	-81.46%
THAR	THARIMMUNE INC	$4.25M	-217.30%	-159.10%	-101.88%	1,250.10%	0.20	6.03	N/A	N/A	N/A
MGTX	MEIRAGTX HOLDINGS PLC	$315.31M	-75.70%	-28.20%	-27.26%	-31.10%	1.37	2.38	N/A	N/A	N/A
ALLK	ALLAKOS INC	$96.66M	-80.30%	-62.10%	-94.69%	-83.30%	0.44	4.92	N/A	N/A	N/A
XTLB	XTL BIOPHARMACEUTICALS LTD	$13.19M	-28.90%	-25.00%	N/A	-54.10%	0.05	N/A	N/A	N/A	N/A
BCAB	BIOATLA INC	$124.09M	-110.60%	-75.40%	-135.21%	699.20%	0.69	4.11	N/A	N/A	N/A
GNPX	GENPREX INC	$4.37M	-245.60%	-185.50%	-416.11%	-16,035.70%	0.44	2.31	N/A	N/A	N/A
AZTR	AZITRA INC	$6.34M	N/A	-180.00%	-316.00%	-274.90%	0.76	1.58	100.00%	-1,842.40%	-1,617.89%
FWBI	FIRST WAVE BIOPHARMA INC	$5.43M	-614.80%	-284.10%	-420.61%	1,616.00%	0.91	1.58	N/A	N/A	N/A
VTYX	VENTYX BIOSCIENCES INC	$227.23M	-62.90%	-57.70%	-75.54%	-73.20%	0.14	11.87	N/A	N/A	N/A
RVNC	REVANCE THERAPEUTICS INC	$325.51M	N/A	-60.10%	-78.19%	-42.90%	-4.16	3.80	68.20%	-138.40%	-130.03%
CAPR	CAPRICOR THERAPEUTICS INC	$167.36M	-299.70%	-45.50%	-81.15%	-365.00%	1.60	1.63	100.00%	-88.50%	-88.52%
APLT	APPLIED THERAPEUTICS INC	$456.37M	N/A	-275.80%	732.54%	270.80%	-4.20	0.76	100.00%	-1,198.50%	-1,198.47%
VIRI	VIRIOS THERAPEUTICS INC	$9.05M	-110.10%	-100.20%	-139.12%	-1,756.10%	0.09	11.62	N/A	N/A	N/A
ONCY	ONCOLYTICS BIOTECH INC	$81.12M	-106.20%	-72.90%	-79.97%	-417.00%	0.41	9.01	N/A	N/A	N/A
XFOR	X4 PHARMACEUTICALS INC	$183.05M	-170.10%	-65.40%	-76.62%	-202.10%	1.88	5.34	N/A	N/A	N/A
PHVS	PHARVARIS NV	$1.23B	-48.00%	-44.60%	N/A	-904.20%	0.04	N/A	N/A	N/A	N/A
CYCC	CYCLACEL PHARMACEUTICALS INC	$1.79M	-450.90%	-152.20%	-3,967.55%	8,016.00%	13.51	0.91	100.00%	-5,418.10%	-6,083.57%
CMMB	CHEMOMAB THERAPEUTICS LTD	$9.66M	-114.00%	-88.50%	-139.90%	-266.70%	0.30	4.32	N/A	N/A	N/A
TSHA	TAYSHA GENE THERAPIES INC	$458.19M	N/A	-80.90%	-78.37%	-1,211.60%	1.31	4.08	100.00%	-722.10%	-689.72%
TLSA	TIZIANA LIFE SCIENCES LTD	$65.97M	-50.60%	-40.90%	-77.67%	-3,014.70%	0.35	3.64	N/A	N/A	N/A
SYRE	SPYRE THERAPEUTICS INC	$1.26B	N/A	-160.40%	-109.34%	6,106.20%	0.40	10.68	100.00%	-38,238.10%	-38,241.08%
PDSB	PDS BIOTECHNOLOGY CORP	$124.34M	-138.40%	-69.00%	-94.07%	-239.80%	1.27	4.33	N/A	N/A	N/A
CRIS	CURIS INC	$86.70M	-169.20%	-54.80%	-74.36%	-108.10%	2.93	4.51	97.90%	-473.00%	-473.04%
CMND	CLEARMIND MEDICINE INC	$3.80M	-265.30%	-121.90%	-155.60%	263.90%	1.00	1.96	N/A	N/A	N/A
INSM	INSMED INC	$3.71B	N/A	-53.40%	-60.25%	-39.00%	-5.01	4.12	78.50%	-245.60%	-217.99%
TARA	PROTARA THERAPEUTICS INC	$35.44M	-49.70%	-43.80%	-55.52%	-67.50%	0.16	11.17	N/A	N/A	N/A
EDSA	EDESA BIOTECH INC	$13.86M	-103.80%	-83.90%	-132.03%	1,545.00%	0.34	2.73	N/A	N/A	N/A
RARE	ULTRAGENYX PHARMACEUTICAL INC	$3.62B	-369.50%	-44.70%	-50.26%	-74.20%	4.41	2.61	89.60%	-139.70%	-140.12%
ENVB	ENVERIC BIOSCIENCES INC	$6.93M	-355.00%	-191.00%	-882.60%	1,051.70%	1.20	1.53	N/A	N/A	N/A
BMEA	BIOMEA FUSION INC	$385.81M	-69.40%	-59.60%	-66.22%	-617.30%	0.18	7.84	N/A	N/A	N/A
HLVX	HILLEVAX INC	$660.03M	-48.20%	-38.10%	-38.45%	-87.90%	0.30	10.62	N/A	N/A	N/A
OPT	OPTHEA LTD	$190.95M	-676.70%	-179.60%	-168.95%	-337.80%	-17.85	5.25	100.00%	-36,992.00%	-35,036.08%
GTBP	GT BIOPHARMA INC	$4.29M	-71.80%	-44.40%	-98.77%	-74.40%	0.89	2.12	N/A	N/A	N/A
GLSI	GREENWICH LIFESCIENCES INC	$162.27M	-93.90%	-91.20%	-132.71%	3,150.80%	0.04	23.76	N/A	N/A	N/A
IMMX	IMMIX BIOPHARMA INC	$55.96M	-100.90%	-86.70%	-95.04%	13,779.00%	0.23	5.32	N/A	N/A	N/A
ENLV	ENLIVEX THERAPEUTICS LTD	$30.87M	-71.00%	-59.10%	-95.53%	-90.40%	0.22	5.57	N/A	N/A	N/A
GHRS	GH RESEARCH PLC	$559.30M	-15.50%	-15.00%	-15.88%	-24.90%	0.03	24.49	N/A	N/A	N/A
MBRX	MOLECULIN BIOTECH INC	$11.16M	-80.90%	-67.70%	-94.80%	1,710.60%	0.47	3.86	N/A	N/A	N/A
GNTA	GENENTA SCIENCE SPA	$53.74M	-45.20%	-41.80%	-55.00%	-123.40%	0.09	12.25	N/A	N/A	N/A
PIRS	PIERIS PHARMACEUTICALS INC	$14.48M	-86.70%	-36.70%	-91.72%	-191.50%	0.45	3.24	100.00%	-57.30%	-57.33%
TOVX	THERIVA BIOLOGICS INC	$7.20M	-42.90%	-29.30%	-41.23%	-101.70%	0.42	4.07	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the top biotech stock with a Zen Score of 75, which is 52 points higher than the biotech industry average of 23. It passed 24 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -30.24% over the past year, underperforming other biotech stocks by -8 percentage points.

Incyte has an average 1 year price target of $74.69, an upside of 42.11% from Incyte's current stock price of $52.56.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 23.08% have issued a Strong Buy rating, 23.08% have issued a Buy, 53.85% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second best biotech stock with a Zen Score of 70, which is 47 points higher than the biotech industry average of 23. It passed 23 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -10.71% over the past year, overperforming other biotech stocks by 12 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $37.33, an upside of 27.63% from Harmony Biosciences Holdings's current stock price of $29.25.

Harmony Biosciences Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Harmony Biosciences Holdings, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 16.67% have issued a Sell rating, and 16.67% have issued a Strong Sell.

3. Voyager Therapeutics (NASDAQ:VYGR)

Voyager Therapeutics (NASDAQ:VYGR) is the third best biotech stock with a Zen Score of 66, which is 43 points higher than the biotech industry average of 23. It passed 21 out of 33 due diligence checks and has strong fundamentals. Voyager Therapeutics has seen its stock return 7.32% over the past year, overperforming other biotech stocks by 30 percentage points.

Voyager Therapeutics has an average 1 year price target of $20.50, an upside of 163.84% from Voyager Therapeutics's current stock price of $7.77.

Voyager Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Voyager Therapeutics, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Carisma Therapeutics (NASDAQ:CARM)

Carisma Therapeutics (NASDAQ:CARM) has an annual dividend yield of N/A, which is N/A percentage points lower than the biotech industry average of 14.95%.

Carisma Therapeutics's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

2. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 56.82%, which is 42 percentage points higher than the biotech industry average of 14.95%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk A S (NYSE:NVO)

Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.08%, which is -14 percentage points lower than the biotech industry average of 14.95%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% eight times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 38.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.46% in the last day, and up 1.78% over the last week. Immunitybio was the among the top gainers in the biotechnology industry, gaining 22.31% yesterday.

ImmunityBio shares are trading higher after Piper Sandler maintained a Neutral rating on the stock and raised its price target from $5 to $6.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 100, which is 86 points higher than the biotech industry average of 14. It passed 7 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -20.41% in the past year. It has overperformed other stocks in the biotech industry by 2 percentage points.

2. Voyager Therapeutics (NASDAQ:VYGR)

Voyager Therapeutics (NASDAQ:VYGR) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Voyager Therapeutics has a valuation score of 100, which is 86 points higher than the biotech industry average of 14. It passed 7 out of 7 valuation due diligence checks.

Voyager Therapeutics's stock has gained 7.32% in the past year. It has overperformed other stocks in the biotech industry by 30 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -30.24% in the past year. It has underperformed other stocks in the biotech industry by -8 percentage points.

Are biotech stocks a good buy now?

49.42% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 88.66% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 14.39x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.